Cancer leaders assess the impact on the cancer patient of the historic passage of Patient Protection and Affordable Care Act (HR 3590) (PPACA). The Association of Cancer Executives, a national organization for leadership development of oncology executives and improvements in patient care delivery, and the Association of Community Cancer Centers, a leading education and advocacy organization for the cancer team, weigh in on the impact of PPACA. Oncology leaders assess the impact of PPACA on cancer patients and families, cancer programs in the United States, and provider relations. The provisions of PPACA most impacting cancer patients are reviewed, including reimbursement changes, expansion of prevention and screening services, the development of accountable care organizations, physician relations, and the implementation of integrated electronic health records. Cancer executives prepare their programs for PPACA by changing the care delivery model to ensure the economic survival of private practices and hospital-based programs.
From the *Clinical Program Development, Renown Institute for Cancer, Renown Regional Medical Center, Reno, NV; †Provider Economics and Public Policy, Association of Community Cancer Centers, Rockville, MD; ‡Oncology Management Consulting Group, Pipersville, PA; and §Cancer Services, Aurora Health Care, Milwaukee, WI.
Sources of Support: The Association of Cancer Executives and the Association of Community Cancer Centers.
Reprints: Linda W. Ferris, PhD, Clinical Program Development, Renown Institute for Cancer, Renown Regional Medical Center, 1155 Mill St, L-11, Reno, NV 89523. E-mail: firstname.lastname@example.org, email@example.com.